Can Johnson & Johnson Challenge Intuitive Surgical After Ottava’s FDA Approval?
The FDA's De Novo authorization of Johnson & Johnson's OTTAVA robotic surgical system marks a significant milestone for the company's MedTech ambitions.
However, it also raises important questions about its potential to disrupt the market dominated by Intuitive Surgical's da Vinci 5 platform.